YMCA of the USA Deepens Collaboration with DaVita to Drive Kidney Health Initiatives in Seven CommunitiesCHICAGO and DENVER, Feb. 27, 2025 (GLOBE NEWSWIRE) -- YMCA of the USA (Y-USA), the national resource office for the 2,600+ YMCAs across the country, is excited to expand its collaboration with DaVita, a leading provider of comprehensive kidney care, to advance chronic disease education and prevention for individuals and their families who are either managing or at risk for chronic kidney disease (CKD). CKD disproportionately affects individuals with risk factors such as hypertension and diabetes.
DaVita Inc. (NYSE: DVA) Making Surprising Moves in Tuesday SessionDaVita Inc. (
NYSEDVA) has caught the attention of the investment community today with its bullish price action. The company’s shares have moved 7.38% on the day to $135.01.
DaVita Inc. (NYSE: DVA) Highlighted for Surprising Price ActionDaVita Inc. (
NYSEDVA) has caught the attention of the investment community today with its bullish price action. The company’s shares have moved -0.17% on the day to $76.64.
DaVita Inc. (NYSE: DVA) Climbs to New 52-Week HighShares of DaVita Inc. (
NYSEDVA) traded at a new 52-week high today and are currently trading at $102.77. So far today, approximately 149.35k shares have been exchanged, as compared to an average 30-day volume of 581.84k shares.
Wall Street Is Cautious on These 2 First Half WinnersThere have been many stock winners in 2023 so far, but Wall Street is feeling cautious on these two first half outperformers.
DaVita Inc. (NYSE: DVA) Making Surprising Moves in Tuesday SessionDaVita Inc. (
NYSEDVA) has caught the attention of the investment community today with its bullish price action. The company’s shares are currently up 13.33% on the day to $101.1.
Mighty Mitochondria: This Company is Developing A Novel Drug for Kidney Disease By Targeting The Powerhouse Of Human CellsYou may remember learning that mitochondria are the powerhouse of the cells, but do you know the dangers that result if these cell superheroes get sick?
Federman & Sherwood Investigates DaVita, Inc. for Data Breach
The law firm of Federman & Sherwood has initiated an investigation into DaVita, Inc. [NYSE: DVA] with respect to a data breach. On September 8, 2022, DaVita, Inc., a healthcare company with approximately 2,816 outpatient dialysis centers in the United States, confirmed that the company experienced a data breach after an unauthorized party accessed sensitive consumer data entrusted to the company. According to DaVita, the breach resulted in the names, addresses, Social Security numbers, medical information and health insurance information of certain individuals being compromised.
